JRCT ID: jRCT1032210360
Registered date:02/10/2021
Examination of safe apheresis implementation method
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Diseases that require leukocyte apheresis |
| Date of first enrollment | 02/10/2021 |
| Target sample size | 15 |
| Countries of recruitment | |
| Study type | Other |
| Intervention(s) | Monitoring during apheresis |
Outcome(s)
| Primary Outcome | Search for appropriate monitoring methods to safely perform leukocyte apheresis. |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | Cases requiring leukocyte apheresis |
| Exclude criteria | (1) Patients for whom consent to participate in the research was not obtained (2) In addition, patients who were deemed inappropriate as a subject by the principal investigator |
Related Information
| Primary Sponsor | Yanagisawa Ryu |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | The Japan Society of Transfusion Medicine and Cell Therapy |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Ryu Yanagisawa |
| Address | 3-1-1 Asashi, Matsumoto, Nagano Nagano Japan 390-8621 |
| Telephone | +81-263-37-3240 |
| ryu@shinshu-u.ac.jp | |
| Affiliation | Shinshu University Hospital |
| Scientific contact | |
| Name | Ryu Yanagisawa |
| Address | 3-1-1 Asashi, Matsumoto, Nagano Nagano Japan 390-8621 |
| Telephone | +81-263-37-3240 |
| ryu@shinshu-u.ac.jp | |
| Affiliation | Shinshu University Hospital |